+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Pneumococcal Vaccine"

From
From
From
From
From
Pneumococcal Vaccine Market Report and Forecast 2024-2032 - Product Thumbnail Image

Pneumococcal Vaccine Market Report and Forecast 2024-2032

  • Report
  • November 2023
  • 160 Pages
  • Global
From
Vaccines and Autoimmunity. Edition No. 1 - Product Thumbnail Image

Vaccines and Autoimmunity. Edition No. 1

  • Book
  • June 2015
  • 392 Pages
Vaccinations - Product Thumbnail Image

Vaccinations

  • Book
  • November 2018
Loading Indicator

The Pneumococcal Vaccine is a type of vaccine used to protect against infection caused by the bacterium Streptococcus pneumoniae. It is used to prevent a range of illnesses, including pneumonia, meningitis, and sepsis. The vaccine is typically administered to infants and young children, as well as adults who are at an increased risk of infection. It is also recommended for adults over the age of 65. The Pneumococcal Vaccine market is a subset of the larger Vaccines market. It is a highly competitive market, with a number of companies offering different types of vaccines. These companies are typically involved in the research, development, and production of the vaccines. They also provide support services such as distribution, marketing, and education. Some of the companies in the Pneumococcal Vaccine market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and Novartis. Show Less Read more